NLS Collaboration

Simsen Diagnostics is announcing a new collaboration with Orion Corporation during a First-in-Human Phase I study to evaluate Orion’s drug candidate, ODM-212. The primary objective of this Phase I study is dose escalation to determine the optimal dosing regimen for ODM-212. The trial will include a heterogeneous patient population with various types of advanced solid […]

The Division of Clinical Neuroscience at Oslo University Hospital and the Swedish drug development company TikoMed have officially signed a research collaboration agreement. Common ambition for the parties is for their collaboration to lead to more knowledge and better treatment options for patients diagnosed with Amyotrophic Lateral Sclerosis – ALS. TikoMed has previously completed and […]

The new innovation district will be developed by the Danish government, the City of Copenhagen, the University of Copenhagen and other local partners building on the geography and content of Copenhagen Science City. Maintaining and improving Denmark’s ability to commercialize innovative ideas is the goal behind Innovation District Copenhagen, a new initiative, where the Danish […]

The LifeFactFuture consortium includes the University of Turku, the University of Helsinki, Orion, some of Finland’s leading life science manufacturers, and data and technology companies. The project, led by the University of Turku and for which Business Finland recently granted EUR 11.7 million funding, seeks to enhance advanced pharmaceutical and life science manufacturing in Finland. […]

The status of national strategies and a common Nordic roadmap. Rare disease companies struggle with a range of challenges, one of which is how to balance funding R&D with a small market size. Healthcare systems and societies also face a balancing act when it comes to rare diseases – between innovation and accessibility. Having a […]

People with rare diseases and disabilities face common challenges in the Nordic region. Small populations in each individual country make it tricky to set up treatment protocols and gather data, for example, and Nordic cooperation is being highlighted as a possible answer to many of the issues. It is the rare that unites, and only […]